Back to search
Peripheral Neuropathy, Secondary to Drugs or Chemicals
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Peripheral Neuropathy, Secondary to Drugs or Chemicals trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Peripheral Neuropathy, Secondary to Drugs or Chemicals trials you may qualify forChemotherapy-induced peripheral neuropathy (CIPN) is a common and often persistent adverse effect of oxaliplatin- and paclitaxel-based chemotherapy. While exerc…
The investigators are doing a research study that will teach us about the tingly pain that people develop when they get chemotherapy.
The cause of Chemotherapy-Induced Peripheral Neuropathy (CIPN) is still unknown. An estimated 55-60% of patients will experience lasting symptoms affecting func…